Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium falciparum GWT1 acyltransferase (PfGWT1) is an essential enzyme located in the endoplasmic reticulum that plays a critical role in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors [1, 2]. It specifically catalyzes the acylation of the inositol ring of glucosaminyl-phosphatidylinositol (GlcN-PI), a necessary step for the subsequent addition of mannose residues in the GPI precursor assembly [3, 4]. In P. falciparum, GPI anchors are the primary means of attaching essential surface proteins, such as Merozoite Surface Protein 1 (MSP1), to the parasite's plasma membrane [2, 4]. These proteins are indispensable for the parasite's ability to invade host erythrocytes and evade the immune system [4]. Inhibition of PfGWT1 disrupts the trafficking of these proteins, leading to a loss of parasite viability and making it a high-priority target for antimalarial drug development [1, 3]. While human cells utilize a homologous enzyme called PIGW, the structural divergence between the two allows for the design of selective inhibitors that minimize host toxicity [3]. Small molecules like Manogepix (APX001) have validated GWT1 as a druggable target in fungi, and similar scaffolds are being explored for their potential as novel antimalarial agents [3, 5]. The essentiality of this pathway across different stages of the parasite life cycle further enhances its appeal as a target for both treatment and transmission blocking [1, 5].
Inhibition of the acylation of the inositol ring of glucosaminyl-phosphatidylinositol (GlcN-PI) during the biosynthesis of glycosylphosphatidylinositol (GPI) anchors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum GWT1 acyltransferase (PfGWT1).